India’s medical devices industry has expressed support for a new ₹500 crore scheme launched by Union Health Minister JP Nadda, aimed at strengthening domestic manufacturing, reducing import dependency, and enhancing exports. Key industry figures see this as a transformative boost for the sector, promising growth, innovation, and export potential.

BulletsIn

• Government launched a ₹500 crore scheme to boost India’s medical devices sector.
• Union Health Minister JP Nadda announced the scheme as a milestone for medtech growth.
• Focus on reducing import reliance, building a robust domestic manufacturing base.
• Industry players see scheme fostering export potential, supporting India’s global positioning.
• Key initiatives include shared infrastructure and medical device cluster facilities.
• Emphasis on capacity building, skill development, and clinical expertise in the workforce.
• Scheme also prioritizes essential component manufacturing, clinical studies, and promotion.
• Industry leaders expect the scheme to encourage cost efficiency and local innovation.
• Dedicated ₹180 crore for Marginal Investment Scheme to strengthen supply chains.
• Additional ₹100 crore allocated for clinical study support to aid regulatory compliance.
• Scheme’s goal: high-quality, globally competitive medical devices, boosting India’s exports.